Valid-NEO: A Multi-Omics Platform for Neoantigen Detection and Quantification from Limited Clinical Samples

SIMPLE SUMMARY: Neoantigens have emerged as highly personalized cancer therapeutic targets in recent years. Numerous studies have reported phenomenal therapeutic efficacy through treatments targeting cancer patient-specific neoantigens. Despite the growing interests, to identify druggable neoantigen...

Descripción completa

Detalles Bibliográficos
Autores principales: Terai, Yuri Laguna, Huang, Chun, Wang, Baoli, Kang, Xiaonan, Han, Jing, Douglass, Jacqueline, Hsiue, Emily Han-Chung, Zhang, Ming, Purohit, Raj, deSilva, Taylor, Wang, Qing
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8909145/
https://www.ncbi.nlm.nih.gov/pubmed/35267551
http://dx.doi.org/10.3390/cancers14051243

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8909145/
https://www.ncbi.nlm.nih.gov/pubmed/35267551
http://dx.doi.org/10.3390/cancers14051243

Ejemplares similares